US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 2.060
  • +0.060+3.00%
Close Nov 27 16:00 ET
  • 1.820
  • -0.240-11.65%
Post 20:02 ET
43.75MMarket Cap-5885P/E (TTM)

OS Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
291.73%2.44M
-48.54%779.8K
-39.87%630.23K
-2.33%4.34M
1.16M
622.21K
1.52M
17.84%1.05M
-8.08%4.45M
889.39K
Selling and administrative expenses
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
-2.87%1.12M
--132.88K
--167.7K
--522.48K
44.65%294.25K
-23.27%1.15M
--203.42K
-General and administrative expense
631.76%1.23M
-26.65%383.23K
-8.78%268.42K
-2.87%1.12M
--132.88K
--167.7K
--522.48K
44.65%294.25K
-23.27%1.15M
--203.42K
Research and development costs
166.27%1.21M
-60.06%396.57K
-52.00%361.81K
-2.26%3.22M
--1.02M
--454.51K
--992.9K
10.08%753.78K
51.39%3.29M
--684.76K
Other operating expenses
----
----
----
325.95%5.15K
----
----
----
----
-99.90%1.21K
--1.21K
Operating profit
-291.73%-2.44M
48.54%-779.8K
39.87%-630.23K
2.33%-4.34M
-1.16M
-622.21K
-1.52M
-17.84%-1.05M
8.08%-4.45M
-889.39K
Net non-operating interest income expense
67.63%-437.84K
21.42%-777.68K
-3.73%-828.76K
-90.72%-3.45M
-307.53K
-1.35M
-989.68K
-68.86%-798.94K
29.99%-1.81M
-473.13K
Non-operating interest income
--0
--1
----
--2
--0
--1
--0
----
--0
----
Non-operating interest expense
-67.63%437.84K
-21.42%777.68K
3.73%828.76K
90.72%3.45M
--307.53K
--1.35M
--989.68K
68.86%798.94K
-29.99%1.81M
--473.13K
Other net income (expense)
Income before tax
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
-1.97M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
Income tax
Net income
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
-1.97M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
Net income continuous Operations
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
---1.46M
---1.97M
---2.51M
-35.56%-1.85M
15.71%-6.25M
---1.36M
Minority interest income
Net income attributable to the parent company
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-1.46M
-1.97M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
Preferred stock dividends
0.00%31.25K
0.00%125K
31.25K
31.25K
31.25K
0.00%31.25K
33.33%125K
31.25K
Other preferred stock dividends
Net income attributable to common stockholders
-43.31%-2.88M
38.59%-1.56M
20.66%-1.49M
-24.09%-7.92M
-1.5M
-2.01M
-2.54M
-34.76%-1.88M
15.10%-6.38M
-1.39M
Basic earnings per share
-79.88%-0.18
40.23%-0.0756
20.66%-0.0743
-24.09%-0.3948
-0.0726
-0.1001
-0.1265
-56.33%-0.0937
2.18%-0.3182
-0.0599
Diluted earnings per share
-79.88%-0.18
40.23%-0.0756
20.66%-0.0743
-24.09%-0.3948
-0.0726
-0.1001
-0.1265
-56.33%-0.0937
2.18%-0.3182
-0.0599
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 291.73%2.44M-48.54%779.8K-39.87%630.23K-2.33%4.34M1.16M622.21K1.52M17.84%1.05M-8.08%4.45M889.39K
Selling and administrative expenses 631.76%1.23M-26.65%383.23K-8.78%268.42K-2.87%1.12M--132.88K--167.7K--522.48K44.65%294.25K-23.27%1.15M--203.42K
-General and administrative expense 631.76%1.23M-26.65%383.23K-8.78%268.42K-2.87%1.12M--132.88K--167.7K--522.48K44.65%294.25K-23.27%1.15M--203.42K
Research and development costs 166.27%1.21M-60.06%396.57K-52.00%361.81K-2.26%3.22M--1.02M--454.51K--992.9K10.08%753.78K51.39%3.29M--684.76K
Other operating expenses ------------325.95%5.15K-----------------99.90%1.21K--1.21K
Operating profit -291.73%-2.44M48.54%-779.8K39.87%-630.23K2.33%-4.34M-1.16M-622.21K-1.52M-17.84%-1.05M8.08%-4.45M-889.39K
Net non-operating interest income expense 67.63%-437.84K21.42%-777.68K-3.73%-828.76K-90.72%-3.45M-307.53K-1.35M-989.68K-68.86%-798.94K29.99%-1.81M-473.13K
Non-operating interest income --0--1------2--0--1--0------0----
Non-operating interest expense -67.63%437.84K-21.42%777.68K3.73%828.76K90.72%3.45M--307.53K--1.35M--989.68K68.86%798.94K-29.99%1.81M--473.13K
Other net income (expense)
Income before tax -45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M-1.97M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M
Income tax
Net income -45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M-1.97M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M
Net income continuous Operations -45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M---1.46M---1.97M---2.51M-35.56%-1.85M15.71%-6.25M---1.36M
Minority interest income
Net income attributable to the parent company -45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M-1.46M-1.97M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M
Preferred stock dividends 0.00%31.25K0.00%125K31.25K31.25K31.25K0.00%31.25K33.33%125K31.25K
Other preferred stock dividends
Net income attributable to common stockholders -43.31%-2.88M38.59%-1.56M20.66%-1.49M-24.09%-7.92M-1.5M-2.01M-2.54M-34.76%-1.88M15.10%-6.38M-1.39M
Basic earnings per share -79.88%-0.1840.23%-0.075620.66%-0.0743-24.09%-0.3948-0.0726-0.1001-0.1265-56.33%-0.09372.18%-0.3182-0.0599
Diluted earnings per share -79.88%-0.1840.23%-0.075620.66%-0.0743-24.09%-0.3948-0.0726-0.1001-0.1265-56.33%-0.09372.18%-0.3182-0.0599
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday-1.11%